Latest Ratings for CI Date Firm Action From To Mar 2022 Mizuho Maintains Buy Feb 2022 SVB Leerink Maintains Market Perform Feb 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for CI View the Latest Analyst Ratings read more
Latest Ratings for NVDA Date Firm Action From To Mar 2022 Goldman Sachs Reinstates Neutral Feb 2022 Summit Insights Group Downgrades Buy Hold Feb 2022 Mizuho Maintains Buy View More Analyst Ratings for NVDA View the Latest Analyst Ratings read more
Direxion MD Edward Egilinsky says traders are locking profits, hedging market highs, and using Palantir inverse ETFs for tactical moves. read more
Latest Ratings for MTZ Date Firm Action From To Feb 2022 Barclays Maintains Overweight Feb 2022 Credit Suisse Maintains Outperform Dec 2021 Credit Suisse Maintains Outperform View More Analyst Ratings for MTZ View the Latest Analyst Ratings read more
Latest Ratings for PH Date Firm Action From To Mar 2022 Mizuho Maintains Neutral Mar 2022 Jefferies Maintains Buy Dec 2021 Mizuho Initiates Coverage On Neutral View More Analyst Ratings for PH View the Latest Analyst Ratings read more
Salesforce shares fall despite strong Q2 results and raised guidance. Data Cloud and AI grow, but weaker outlook tempers investor enthusiasm. Latest Ratings for CRM Date Firm Action From To Mar 2022 Wedbush Maintains Outperform Mar 2022 Canaccord Genuity Maintains Buy Mar 2022 Raymond James Maintains Strong Buy View More Analyst Ratings for CRM View…